These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21976349)

  • 21. Reasons and remedies for underinsurance for child and adolescent vaccines.
    Davis MM
    JAMA; 2007 Aug; 298(6):680-2. PubMed ID: 17684192
    [No Abstract]   [Full Text] [Related]  

  • 22. First countries to be recipients of GAVI funds.
    Maurice J
    Bull World Health Organ; 2000; 78(12):1477-8. PubMed ID: 11196504
    [No Abstract]   [Full Text] [Related]  

  • 23. Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
    Keith JA; Agostini Bigger L; Arthur PA; Maes E; Daems R
    Vaccine; 2013 Apr; 31 Suppl 2():B184-93. PubMed ID: 23598480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A work in progress.
    Bloice C; Hallinan C
    Revolution (Oakl); 2005; 6(6):14-21. PubMed ID: 16422557
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccine utilization study--Prince Edward Island.
    Sweet LE
    Can J Public Health; 1995; 86(3):193-4. PubMed ID: 7671206
    [No Abstract]   [Full Text] [Related]  

  • 26. Shifting the focus of rationing discussions.
    Stark M
    Am J Bioeth; 2011 Jul; 11(7):20-2. PubMed ID: 21745076
    [No Abstract]   [Full Text] [Related]  

  • 27. Apropos "New vaccines for developing countries: will it be feast or famine"?
    Arya SC; Agarwal N
    Am J Law Med; 2009; 35(4):691. PubMed ID: 20196288
    [No Abstract]   [Full Text] [Related]  

  • 28. Provinces providing more childhood vaccines.
    Eggertson L
    CMAJ; 2006 Jan; 174(1):20. PubMed ID: 16389226
    [No Abstract]   [Full Text] [Related]  

  • 29. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The U.S. vaccine supply.
    Hinman AR
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15758020
    [No Abstract]   [Full Text] [Related]  

  • 31. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine.
    Kharbanda EO; Lee GM; Koenigs L;
    J Adolesc Health; 2011 Mar; 48(3):320-1. PubMed ID: 21338909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

  • 33. USA faces chronic vaccine shortages.
    Nelson R
    Lancet Infect Dis; 2004 Feb; 4(2):66. PubMed ID: 14959757
    [No Abstract]   [Full Text] [Related]  

  • 34. Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
    Lee BY; Haidari LA; Prosser W; Connor DL; Bechtel R; Dipuve A; Kassim H; Khanlawia B; Brown ST
    Vaccine; 2016 Sep; 34(41):4998-5004. PubMed ID: 27576077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global health experts explore ways to slash vaccine prices and expand access.
    Zarocostas J
    BMJ; 2011 May; 342():d3287. PubMed ID: 21613348
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of free vaccine and insurance status on physician referral of children to public vaccine clinics.
    Zimmerman RK; Medsger AR; Ricci EM; Raymund M; Mieczkowski TA; Grufferman S
    JAMA; 1997 Sep; 278(12):996-1000. PubMed ID: 9307347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 38. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.